Citigroup began coverage on shares of Adient (NYSE:ADNT – Free Report) in a report published on Wednesday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $14.00 price objective on the stock.
Several other research firms also recently weighed in on ADNT. StockNews.com downgraded Adient from a “buy” rating to a “hold” rating in a research note on Friday, April 18th. Morgan Stanley dropped their target price on Adient from $19.00 to $17.00 and set an “underweight” rating on the stock in a research report on Monday, March 3rd. Barclays lowered shares of Adient from an “equal weight” rating to a “negative” rating in a research report on Tuesday, April 15th. UBS Group dropped their price objective on shares of Adient from $20.00 to $13.00 and set a “neutral” rating on the stock in a report on Thursday, April 10th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Monday, January 27th. Three equities research analysts have rated the stock with a sell rating and eight have issued a hold rating to the stock. According to data from MarketBeat, Adient presently has a consensus rating of “Hold” and a consensus target price of $18.44.
Read Our Latest Stock Analysis on Adient
Adient Stock Performance
Adient (NYSE:ADNT – Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same quarter in the previous year, the firm posted $0.31 earnings per share. Sell-side analysts expect that Adient will post 1.76 EPS for the current year.
Institutional Trading of Adient
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADNT. Pzena Investment Management LLC boosted its stake in shares of Adient by 28.5% during the 4th quarter. Pzena Investment Management LLC now owns 3,629,452 shares of the company’s stock worth $62,535,000 after acquiring an additional 803,961 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in Adient during the fourth quarter worth approximately $11,395,000. Millennium Management LLC grew its holdings in Adient by 2,039.0% in the fourth quarter. Millennium Management LLC now owns 610,312 shares of the company’s stock valued at $10,516,000 after purchasing an additional 581,779 shares during the period. HITE Hedge Asset Management LLC increased its position in shares of Adient by 122.4% in the fourth quarter. HITE Hedge Asset Management LLC now owns 816,286 shares of the company’s stock valued at $14,065,000 after buying an additional 449,272 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Adient by 96.5% during the 4th quarter. JPMorgan Chase & Co. now owns 802,540 shares of the company’s stock worth $13,828,000 after buying an additional 394,111 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Further Reading
- Five stocks we like better than Adient
- Dividend Capture Strategy: What You Need to Know
- Short Sellers Gave Up on These 3 Names Recently
- Do ETFs Pay Dividends? What You Need to Know
- 3 Boring Stocks Outperforming the Market This Year
- How to Evaluate a Stock Before Buying
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.